Curis (CRIS) Cash Flow Statement

Click line-items for a historical chart and %

Net (loss)/income	-49.08M
Depreciation and amortization	141K
Stock-based compensation expense	3.31M
Change in fair value of warrant liability
Non-cash interest expense (income)	83K
Net gain on sale of assets
Accounts receivable	249K
Prepaid expenses and other assets	-265K
Accounts payable and accrued liabilities	1.11M
Deferred revenue
Total adjustments	22.65M
Net cash (used in)/provided by operating activities
Purchase of marketable securities	-50.49M
Sales of marketable securities	66.82M
Purchases of property and equipment	-269K
Proceeds from sale of assets
Decrease in restricted cash	0
Net cash provided by/(used in) investing activities
Proceeds from registered direct offering of common stock and warrants, net of issuance costs of $1,310,000
Proceeds from other issuances of common stock and exercise of warrants
Net cash provided by financing activities
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	-12.42M
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	33.09M
CASH AND CASH EQUIVALENTS, END OF PERIOD	20.67M

Entities mentioned with CRIS

View All Entities